| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $545.5M | +17.7% |
| Cost of Revenue | $329.9M | +15.7% |
| Gross Profit | $215.6M | +21.0% |
| R&D Expense | $39.3M | +14.1% |
| SG&A Expense | $65.0M | -8.4% |
| Operating Income | -$56.1M | +23.7% |
| Interest Expense | $4.8M | -0.7% |
| Pre-tax Income | -$50.4M | +25.6% |
| Income Tax | -$21K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.2M | -58.4% |
| Short-term Investments | $217.6M | +1.0% |
| Accounts Receivable | $74.0M | +5.5% |
| Inventory | $3.9M | +35.7% |
| Current Assets | $327.5M | -8.1% |
| Total Assets | $680.1M | -3.9% |
| Current Liabilities | $74.8M | -10.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.4M | +48.5% |
| Capital Expenditures | $18.1M | -2.1% |
| Investing Cash Flow | -$20.2M | -220.1% |
| Financing Cash Flow | $4.6M | +334.8% |
| Free Cash Flow | -$33.5M | +30.8% |
| +94.1% |
| Net Income | -$50.4M | +25.3% |
| EPS (Basic) | -$1.03 | +27.0% |
| EPS (Diluted) | -$1.03 | +27.0% |
| Total Liabilities |
| $364.5M |
| -3.3% |
| Stockholders' Equity | $314.5M | -4.5% |